Back to all bills
HR 1266119th CongressIntroduced
Combating Illicit Xylazine Act
Introduced: Oct 29, 2025
Civil Rights & JusticeDefense & National SecurityHealthcare
Standard Summary
Comprehensive overview in 1-2 paragraphs
The Combating Illicit Xylazine Act aims to control xylazine by adding it to Schedule III of the Controlled Substances Act, defining lawful possession for veterinary purposes, enhancing DEA tracking, and adjusting sentencing guidelines to address its misuse.
Key Points
- 1Adds xylazine to Schedule III of the Controlled Substances Act to restrict illicit use.
- 2Defines 'ultimate user' to permit possession for veterinary and animal-control purposes.
- 3Requires DEA and FDA collaboration on reports assessing xylazine diversion and abuse risks.
Impact Areas
Veterinarians and animal care professionalsDrug Enforcement Administration (DEA)Food and Drug Administration (FDA)Law enforcement and judicial systemsIllicit drug trafficking and public health sectors
Generated by Legislative Analysis AI v3 on Nov 10, 2025